#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=The devastating threat of antimicrobial resistance ( AMR ) to global human health is unquestionable .
2-1	16-19	The	abstract[2]	new[2]	_	_
2-2	20-31	devastating	abstract[2]	new[2]	_	_
2-3	32-38	threat	abstract[2]	new[2]	_	_
2-4	39-41	of	abstract[2]	new[2]	_	_
2-5	42-55	antimicrobial	abstract[2]|abstract[3]	new[2]|new[3]	coref	17-6[137_3]
2-6	56-66	resistance	abstract[2]|abstract[3]	new[2]|new[3]	_	_
2-7	67-68	(	abstract[2]	new[2]	_	_
2-8	69-72	AMR	abstract[2]|organization	new[2]|new	coref	3-16
2-9	73-74	)	abstract[2]	new[2]	_	_
2-10	75-77	to	abstract[2]	new[2]	_	_
2-11	78-84	global	abstract[2]|abstract[5]	new[2]|new[5]	coref	5-7[0_5]
2-12	85-90	human	abstract[2]|abstract[5]	new[2]|new[5]	_	_
2-13	91-97	health	abstract[2]|abstract[5]	new[2]|new[5]	_	_
2-14	98-100	is	_	_	_	_
2-15	101-115	unquestionable	_	_	_	_
2-16	116-117	.	_	_	_	_

#Text=Antimicrobials are losing their effectiveness in treating infections , due to the rapid emergence of AMR and the drying up of antimicrobial pipelines .
3-1	118-132	Antimicrobials	abstract	new	ana	3-4
3-2	133-136	are	_	_	_	_
3-3	137-143	losing	_	_	_	_
3-4	144-149	their	abstract|abstract[8]	giv|new[8]	coref|coref	6-15|6-15
3-5	150-163	effectiveness	abstract[8]	new[8]	_	_
3-6	164-166	in	_	_	_	_
3-7	167-175	treating	_	_	_	_
3-8	176-186	infections	abstract	new	coref	4-1[15_0]
3-9	187-188	,	_	_	_	_
3-10	189-192	due	_	_	_	_
3-11	193-195	to	_	_	_	_
3-12	196-199	the	event[10]	new[10]	_	_
3-13	200-205	rapid	event[10]	new[10]	_	_
3-14	206-215	emergence	event[10]	new[10]	_	_
3-15	216-218	of	event[10]	new[10]	_	_
3-16	219-222	AMR	event[10]|event	new[10]|giv	coref	4-3
3-17	223-226	and	event[10]	new[10]	_	_
3-18	227-230	the	event[10]|event[12]	new[10]|new[12]	_	_
3-19	231-237	drying	event[10]|event[12]	new[10]|new[12]	_	_
3-20	238-240	up	event[10]|event[12]	new[10]|new[12]	_	_
3-21	241-243	of	event[10]|event[12]	new[10]|new[12]	_	_
3-22	244-257	antimicrobial	event[10]|event[12]|object[13]	new[10]|new[12]|new[13]	_	_
3-23	258-267	pipelines	event[10]|event[12]|object[13]	new[10]|new[12]|new[13]	_	_
3-24	268-269	.	_	_	_	_

#Text=The difficult-to-treat AMR infections require longer hospital stays and more costly treatment , increase morbidity and mortality , and reduce productivity ; therefore , increasing the economic burden of the countries .
4-1	270-273	The	abstract[15]	giv[15]	coref	9-10[52_15]
4-2	274-292	difficult-to-treat	abstract[15]	giv[15]	_	_
4-3	293-296	AMR	organization|abstract[15]	giv|giv[15]	coref	6-6
4-4	297-307	infections	abstract[15]	giv[15]	_	_
4-5	308-315	require	_	_	_	_
4-6	316-322	longer	place[16]	new[16]	_	_
4-7	323-331	hospital	place[16]	new[16]	_	_
4-8	332-337	stays	_	_	_	_
4-9	338-341	and	_	_	_	_
4-10	342-346	more	abstract[17]	new[17]	_	_
4-11	347-353	costly	abstract[17]	new[17]	_	_
4-12	354-363	treatment	abstract[17]	new[17]	_	_
4-13	364-365	,	_	_	_	_
4-14	366-374	increase	_	_	_	_
4-15	375-384	morbidity	abstract	new	_	_
4-16	385-388	and	_	_	_	_
4-17	389-398	mortality	event	new	coref	13-14[100_0]
4-18	399-400	,	_	_	_	_
4-19	401-404	and	_	_	_	_
4-20	405-411	reduce	_	_	_	_
4-21	412-424	productivity	abstract	new	_	_
4-22	425-426	;	_	_	_	_
4-23	427-436	therefore	_	_	_	_
4-24	437-438	,	_	_	_	_
4-25	439-449	increasing	_	_	_	_
4-26	450-453	the	abstract[21]	new[21]	_	_
4-27	454-462	economic	abstract[21]	new[21]	_	_
4-28	463-469	burden	abstract[21]	new[21]	_	_
4-29	470-472	of	abstract[21]	new[21]	_	_
4-30	473-476	the	abstract[21]|place[22]	new[21]|new[22]	_	_
4-31	477-486	countries	abstract[21]|place[22]	new[21]|new[22]	_	_
4-32	487-488	.	_	_	_	_

#Text=In recent years , this global health crisis has been gaining much attention in Malaysia , and Malaysia has been striving hard to combat it via different approaches .
5-1	489-491	In	_	_	_	_
5-2	492-498	recent	time[23]	new[23]	_	_
5-3	499-504	years	time[23]	new[23]	_	_
5-4	505-506	,	_	_	_	_
5-5	507-511	this	abstract[25]	new[25]	coref	17-17[140_25]
5-6	512-518	global	abstract[25]	new[25]	_	_
5-7	519-525	health	abstract|abstract[25]	giv|new[25]	coref	15-11
5-8	526-532	crisis	abstract[25]	new[25]	_	_
5-9	533-536	has	_	_	_	_
5-10	537-541	been	_	_	_	_
5-11	542-549	gaining	_	_	_	_
5-12	550-554	much	abstract[26]	new[26]	ana	5-25[0_26]
5-13	555-564	attention	abstract[26]	new[26]	_	_
5-14	565-567	in	abstract[26]	new[26]	_	_
5-15	568-576	Malaysia	abstract[26]|place	new[26]|new	coref	5-18
5-16	577-578	,	_	_	_	_
5-17	579-582	and	_	_	_	_
5-18	583-591	Malaysia	place	giv	coref	27-21
5-19	592-595	has	_	_	_	_
5-20	596-600	been	_	_	_	_
5-21	601-609	striving	_	_	_	_
5-22	610-614	hard	_	_	_	_
5-23	615-617	to	_	_	_	_
5-24	618-624	combat	_	_	_	_
5-25	625-627	it	abstract	giv	_	_
5-26	628-631	via	_	_	_	_
5-27	632-641	different	abstract[30]	new[30]	_	_
5-28	642-652	approaches	abstract[30]	new[30]	_	_
5-29	653-654	.	_	_	_	_

#Text=The major contributing factors of AMR are known to be overuse and misuse of antimicrobials .
6-1	655-658	The	abstract[31]	new[31]	_	_
6-2	659-664	major	abstract[31]	new[31]	_	_
6-3	665-677	contributing	abstract[31]	new[31]	_	_
6-4	678-685	factors	abstract[31]	new[31]	_	_
6-5	686-688	of	abstract[31]	new[31]	_	_
6-6	689-692	AMR	abstract[31]|object	new[31]|giv	coref	10-21
6-7	693-696	are	_	_	_	_
6-8	697-702	known	_	_	_	_
6-9	703-705	to	_	_	_	_
6-10	706-708	be	_	_	_	_
6-11	709-716	overuse	abstract	new	coref	22-9[181_0]
6-12	717-720	and	_	_	_	_
6-13	721-727	misuse	abstract[34]	new[34]	_	_
6-14	728-730	of	abstract[34]	new[34]	_	_
6-15	731-745	antimicrobials	abstract[34]|substance	new[34]|giv	_	_
6-16	746-747	.	_	_	_	_

#Text=Antibiotic consumption by the elderly population was found to be between 11 % to 45 % , with a significant rise over the past decade .
7-1	748-758	Antibiotic	substance|abstract[37]	new|new[37]	coref|coref|coref|coref	8-9|11-4[80_37]|8-9|11-4[80_37]
7-2	759-770	consumption	abstract[37]	new[37]	_	_
7-3	771-773	by	abstract[37]	new[37]	_	_
7-4	774-777	the	abstract[37]|person[38]	new[37]|new[38]	coref	9-12[53_38]
7-5	778-785	elderly	abstract[37]|person[38]	new[37]|new[38]	_	_
7-6	786-796	population	abstract[37]|person[38]	new[37]|new[38]	_	_
7-7	797-800	was	_	_	_	_
7-8	801-806	found	_	_	_	_
7-9	807-809	to	_	_	_	_
7-10	810-812	be	_	_	_	_
7-11	813-820	between	_	_	_	_
7-12	821-823	11	quantity[39]	new[39]	coref	11-13[82_39]
7-13	824-825	%	quantity[39]	new[39]	_	_
7-14	826-828	to	quantity[39]	new[39]	_	_
7-15	829-831	45	quantity[39]|quantity[40]	new[39]|new[40]	_	_
7-16	832-833	%	quantity[39]|quantity[40]	new[39]|new[40]	_	_
7-17	834-835	,	_	_	_	_
7-18	836-840	with	_	_	_	_
7-19	841-842	a	event[41]	new[41]	_	_
7-20	843-854	significant	event[41]	new[41]	_	_
7-21	855-859	rise	event[41]	new[41]	_	_
7-22	860-864	over	event[41]	new[41]	_	_
7-23	865-868	the	event[41]|time[42]	new[41]|new[42]	_	_
7-24	869-873	past	event[41]|time[42]	new[41]|new[42]	_	_
7-25	874-880	decade	event[41]|time[42]	new[41]|new[42]	_	_
7-26	881-882	.	_	_	_	_

#Text=As much as 18 % of the total antibiotic prescriptions in older adults was unnecessary , with 54 % of them prescribed for acute respiratory conditions .
8-1	883-885	As	_	_	_	_
8-2	886-890	much	_	_	_	_
8-3	891-893	as	_	_	_	_
8-4	894-896	18	_	_	_	_
8-5	897-898	%	_	_	_	_
8-6	899-901	of	_	_	_	_
8-7	902-905	the	abstract[44]	new[44]	ana	8-21[0_44]
8-8	906-911	total	abstract[44]	new[44]	_	_
8-9	912-922	antibiotic	substance|abstract[44]	giv|new[44]	coref	16-6
8-10	923-936	prescriptions	abstract[44]	new[44]	_	_
8-11	937-939	in	abstract[44]	new[44]	_	_
8-12	940-945	older	abstract[44]|person[45]	new[44]|new[45]	coref	13-1[97_45]
8-13	946-952	adults	abstract[44]|person[45]	new[44]|new[45]	_	_
8-14	953-956	was	_	_	_	_
8-15	957-968	unnecessary	_	_	_	_
8-16	969-970	,	_	_	_	_
8-17	971-975	with	_	_	_	_
8-18	976-978	54	quantity[46]	new[46]	_	_
8-19	979-980	%	quantity[46]	new[46]	_	_
8-20	981-983	of	quantity[46]	new[46]	_	_
8-21	984-988	them	quantity[46]|abstract	new[46]|giv	coref	20-33
8-22	989-999	prescribed	_	_	_	_
8-23	1000-1003	for	_	_	_	_
8-24	1004-1009	acute	abstract[48]	new[48]	_	_
8-25	1010-1021	respiratory	abstract[48]	new[48]	_	_
8-26	1022-1032	conditions	abstract[48]	new[48]	_	_
8-27	1033-1034	.	_	_	_	_

#Text=Healthcare providers face challenges in adequately diagnosing and managing infections in this vulnerable population because of the altered drug metabolism in this particular group , the common occurrence of drug â€“ drug interactions due to polypharmacy and lower medication adherence .
9-1	1035-1045	Healthcare	organization|person[50]	new|new[50]	_	_
9-2	1046-1055	providers	person[50]	new[50]	_	_
9-3	1056-1060	face	_	_	_	_
9-4	1061-1071	challenges	abstract	new	_	_
9-5	1072-1074	in	_	_	_	_
9-6	1075-1085	adequately	_	_	_	_
9-7	1086-1096	diagnosing	_	_	_	_
9-8	1097-1100	and	_	_	_	_
9-9	1101-1109	managing	_	_	_	_
9-10	1110-1120	infections	abstract[52]	giv[52]	coref	12-5[0_52]
9-11	1121-1123	in	abstract[52]	giv[52]	_	_
9-12	1124-1128	this	abstract[52]|person[53]	giv[52]|giv[53]	coref	12-9[89_53]
9-13	1129-1139	vulnerable	abstract[52]|person[53]	giv[52]|giv[53]	_	_
9-14	1140-1150	population	abstract[52]|person[53]	giv[52]|giv[53]	_	_
9-15	1151-1158	because	abstract[52]|person[53]	giv[52]|giv[53]	_	_
9-16	1159-1161	of	abstract[52]|person[53]	giv[52]|giv[53]	_	_
9-17	1162-1165	the	abstract[52]|person[53]|abstract[55]	giv[52]|giv[53]|new[55]	_	_
9-18	1166-1173	altered	abstract[52]|person[53]|abstract[55]	giv[52]|giv[53]|new[55]	_	_
9-19	1174-1178	drug	abstract[52]|person[53]|substance|abstract[55]	giv[52]|giv[53]|new|new[55]	coref	9-30
9-20	1179-1189	metabolism	abstract[52]|person[53]|abstract[55]	giv[52]|giv[53]|new[55]	_	_
9-21	1190-1192	in	abstract[52]|person[53]|abstract[55]	giv[52]|giv[53]|new[55]	_	_
9-22	1193-1197	this	abstract[52]|person[53]|abstract[55]|person[56]	giv[52]|giv[53]|new[55]|new[56]	_	_
9-23	1198-1208	particular	abstract[52]|person[53]|abstract[55]|person[56]	giv[52]|giv[53]|new[55]|new[56]	_	_
9-24	1209-1214	group	abstract[52]|person[53]|abstract[55]|person[56]	giv[52]|giv[53]|new[55]|new[56]	_	_
9-25	1215-1216	,	abstract[52]|person[53]	giv[52]|giv[53]	_	_
9-26	1217-1220	the	abstract[52]|person[53]|abstract[57]	giv[52]|giv[53]|new[57]	_	_
9-27	1221-1227	common	abstract[52]|person[53]|abstract[57]	giv[52]|giv[53]|new[57]	_	_
9-28	1228-1238	occurrence	abstract[52]|person[53]|abstract[57]	giv[52]|giv[53]|new[57]	_	_
9-29	1239-1241	of	abstract[52]|person[53]|abstract[57]	giv[52]|giv[53]|new[57]	_	_
9-30	1242-1246	drug	abstract[52]|person[53]|abstract[57]|substance	giv[52]|giv[53]|new[57]|giv	coref	9-32
9-31	1247-1248	â€“	_	_	_	_
9-32	1249-1253	drug	substance|abstract[60]	giv|new[60]	_	_
9-33	1254-1266	interactions	abstract[60]	new[60]	_	_
9-34	1267-1270	due	abstract[60]	new[60]	_	_
9-35	1271-1273	to	_	_	_	_
9-36	1274-1286	polypharmacy	abstract	new	_	_
9-37	1287-1290	and	_	_	_	_
9-38	1291-1296	lower	abstract[63]	new[63]	_	_
9-39	1297-1307	medication	substance|abstract[63]	new|new[63]	_	_
9-40	1308-1317	adherence	abstract[63]	new[63]	_	_
9-41	1318-1319	.	_	_	_	_

#Text=Nursing homes or long term care facilities in the United States and Australia were found to be a reservoir for AMR pathogens due to excessive , inappropriate and prolonged broad-spectrum antimicrobial use , inadequate infection control and increased risk of pathogen colonization .
10-1	1320-1327	Nursing	_	_	_	_
10-2	1328-1333	homes	place	new	coref	11-7[81_0]
10-3	1334-1336	or	_	_	_	_
10-4	1337-1341	long	place[66]	new[66]	_	_
10-5	1342-1346	term	place[66]	new[66]	_	_
10-6	1347-1351	care	abstract|place[66]	new|new[66]	_	_
10-7	1352-1362	facilities	place[66]	new[66]	_	_
10-8	1363-1365	in	place[66]	new[66]	_	_
10-9	1366-1369	the	place[66]|place[67]	new[66]|new[67]	coref	11-16[83_67]
10-10	1370-1376	United	place[66]|place[67]	new[66]|new[67]	_	_
10-11	1377-1383	States	place[66]|place[67]	new[66]|new[67]	_	_
10-12	1384-1387	and	place[66]	new[66]	_	_
10-13	1388-1397	Australia	place[66]|place	new[66]|new	_	_
10-14	1398-1402	were	_	_	_	_
10-15	1403-1408	found	_	_	_	_
10-16	1409-1411	to	_	_	_	_
10-17	1412-1414	be	_	_	_	_
10-18	1415-1416	a	abstract[69]	new[69]	_	_
10-19	1417-1426	reservoir	abstract[69]	new[69]	_	_
10-20	1427-1430	for	abstract[69]	new[69]	_	_
10-21	1431-1434	AMR	abstract[69]|organization|abstract[71]	new[69]|giv|new[71]	_	_
10-22	1435-1444	pathogens	abstract[69]|abstract[71]	new[69]|new[71]	_	_
10-23	1445-1448	due	abstract[69]|abstract[71]	new[69]|new[71]	_	_
10-24	1449-1451	to	abstract[69]|abstract[71]	new[69]|new[71]	_	_
10-25	1452-1461	excessive	abstract[69]|abstract[71]|abstract[72]|abstract[73]	new[69]|new[71]|new[72]|new[73]	coref|coref|coref|coref	11-29[86_72]|27-27[230_73]|11-29[86_72]|27-27[230_73]
10-26	1462-1463	,	abstract[69]|abstract[71]|abstract[72]|abstract[73]	new[69]|new[71]|new[72]|new[73]	_	_
10-27	1464-1477	inappropriate	abstract[69]|abstract[71]|abstract[72]|abstract[73]	new[69]|new[71]|new[72]|new[73]	_	_
10-28	1478-1481	and	abstract[69]|abstract[71]|abstract[72]|abstract[73]	new[69]|new[71]|new[72]|new[73]	_	_
10-29	1482-1491	prolonged	abstract[69]|abstract[71]|abstract[72]|abstract[73]	new[69]|new[71]|new[72]|new[73]	_	_
10-30	1492-1506	broad-spectrum	abstract[69]|abstract[71]|abstract[72]|abstract[73]	new[69]|new[71]|new[72]|new[73]	_	_
10-31	1507-1520	antimicrobial	abstract[69]|abstract[71]|abstract[72]|abstract[73]	new[69]|new[71]|new[72]|new[73]	_	_
10-32	1521-1524	use	abstract[69]|abstract[71]|abstract[72]|abstract[73]	new[69]|new[71]|new[72]|new[73]	_	_
10-33	1525-1526	,	abstract[69]|abstract[71]|abstract[73]	new[69]|new[71]|new[73]	_	_
10-34	1527-1537	inadequate	abstract[69]|abstract[71]|abstract[73]|abstract[75]	new[69]|new[71]|new[73]|new[75]	_	_
10-35	1538-1547	infection	abstract[69]|abstract[71]|abstract[73]|abstract|abstract[75]	new[69]|new[71]|new[73]|new|new[75]	_	_
10-36	1548-1555	control	abstract[69]|abstract[71]|abstract[73]|abstract[75]	new[69]|new[71]|new[73]|new[75]	_	_
10-37	1556-1559	and	abstract[69]|abstract[71]|abstract[73]	new[69]|new[71]|new[73]	_	_
10-38	1560-1569	increased	abstract[69]|abstract[71]|abstract[73]|abstract[76]	new[69]|new[71]|new[73]|new[76]	_	_
10-39	1570-1574	risk	abstract[69]|abstract[71]|abstract[73]|abstract[76]	new[69]|new[71]|new[73]|new[76]	_	_
10-40	1575-1577	of	abstract[69]|abstract[71]|abstract[73]|abstract[76]	new[69]|new[71]|new[73]|new[76]	_	_
10-41	1578-1586	pathogen	abstract[69]|abstract[71]|abstract[73]|abstract[76]|place|abstract[78]	new[69]|new[71]|new[73]|new[76]|new|new[78]	_	_
10-42	1587-1599	colonization	abstract[69]|abstract[71]|abstract[73]|abstract[76]|abstract[78]	new[69]|new[71]|new[73]|new[76]|new[78]	_	_
10-43	1600-1601	.	_	_	_	_

#Text=The prevalence of antimicrobial consumption in nursing homes was reported to be 11 % in the United States , where only 66 % of it was documented for therapeutic use .
11-1	1602-1605	The	abstract[79]	new[79]	_	_
11-2	1606-1616	prevalence	abstract[79]	new[79]	_	_
11-3	1617-1619	of	abstract[79]	new[79]	_	_
11-4	1620-1633	antimicrobial	abstract[79]|abstract[80]	new[79]|giv[80]	ana	11-25[0_80]
11-5	1634-1645	consumption	abstract[79]|abstract[80]	new[79]|giv[80]	_	_
11-6	1646-1648	in	abstract[79]|abstract[80]	new[79]|giv[80]	_	_
11-7	1649-1656	nursing	abstract[79]|abstract[80]|place[81]	new[79]|giv[80]|giv[81]	_	_
11-8	1657-1662	homes	abstract[79]|abstract[80]|place[81]	new[79]|giv[80]|giv[81]	_	_
11-9	1663-1666	was	_	_	_	_
11-10	1667-1675	reported	_	_	_	_
11-11	1676-1678	to	_	_	_	_
11-12	1679-1681	be	_	_	_	_
11-13	1682-1684	11	quantity[82]	giv[82]	_	_
11-14	1685-1686	%	quantity[82]	giv[82]	_	_
11-15	1687-1689	in	quantity[82]	giv[82]	_	_
11-16	1690-1693	the	quantity[82]|place[83]	giv[82]|giv[83]	_	_
11-17	1694-1700	United	quantity[82]|place[83]	giv[82]|giv[83]	_	_
11-18	1701-1707	States	quantity[82]|place[83]	giv[82]|giv[83]	_	_
11-19	1708-1709	,	_	_	_	_
11-20	1710-1715	where	_	_	_	_
11-21	1716-1720	only	quantity[84]	new[84]	_	_
11-22	1721-1723	66	quantity[84]	new[84]	_	_
11-23	1724-1725	%	quantity[84]	new[84]	_	_
11-24	1726-1728	of	quantity[84]	new[84]	_	_
11-25	1729-1731	it	quantity[84]|abstract	new[84]|giv	_	_
11-26	1732-1735	was	_	_	_	_
11-27	1736-1746	documented	_	_	_	_
11-28	1747-1750	for	_	_	_	_
11-29	1751-1762	therapeutic	abstract[86]	giv[86]	coref	16-6[124_86]
11-30	1763-1766	use	abstract[86]	giv[86]	_	_
11-31	1767-1768	.	_	_	_	_

#Text=The reported incidence of infections was higher in the older adult population because of the presence of chronic comorbidities , deteriorating organ functions and reduced host defence system .
12-1	1769-1772	The	abstract[87]	new[87]	_	_
12-2	1773-1781	reported	abstract[87]	new[87]	_	_
12-3	1782-1791	incidence	abstract[87]	new[87]	_	_
12-4	1792-1794	of	abstract[87]	new[87]	_	_
12-5	1795-1805	infections	abstract[87]|abstract	new[87]|giv	coref	13-11[99_0]
12-6	1806-1809	was	_	_	_	_
12-7	1810-1816	higher	_	_	_	_
12-8	1817-1819	in	_	_	_	_
12-9	1820-1823	the	person[89]	giv[89]	coref	27-16[224_89]
12-10	1824-1829	older	person[89]	giv[89]	_	_
12-11	1830-1835	adult	person[89]	giv[89]	_	_
12-12	1836-1846	population	person[89]	giv[89]	_	_
12-13	1847-1854	because	_	_	_	_
12-14	1855-1857	of	_	_	_	_
12-15	1858-1861	the	abstract[90]	new[90]	_	_
12-16	1862-1870	presence	abstract[90]	new[90]	_	_
12-17	1871-1873	of	abstract[90]	new[90]	_	_
12-18	1874-1881	chronic	abstract[90]|abstract[91]	new[90]|new[91]	_	_
12-19	1882-1895	comorbidities	abstract[90]|abstract[91]	new[90]|new[91]	_	_
12-20	1896-1897	,	_	_	_	_
12-21	1898-1911	deteriorating	_	_	_	_
12-22	1912-1917	organ	abstract|abstract[93]	new|new[93]	_	_
12-23	1918-1927	functions	abstract[93]	new[93]	_	_
12-24	1928-1931	and	_	_	_	_
12-25	1932-1939	reduced	abstract[96]	new[96]	_	_
12-26	1940-1944	host	person|abstract[96]	new|new[96]	_	_
12-27	1945-1952	defence	abstract|abstract[96]	new|new[96]	_	_
12-28	1953-1959	system	abstract[96]	new[96]	_	_
12-29	1960-1961	.	_	_	_	_

#Text=Older adults also have poorer outcomes as a consequence of infections , including higher mortality , compared to adults of other age groups .
13-1	1962-1967	Older	person[97]	giv[97]	coref	13-19[101_97]
13-2	1968-1974	adults	person[97]	giv[97]	_	_
13-3	1975-1979	also	_	_	_	_
13-4	1980-1984	have	_	_	_	_
13-5	1985-1991	poorer	abstract[98]	new[98]	coref	14-27[114_98]
13-6	1992-2000	outcomes	abstract[98]	new[98]	_	_
13-7	2001-2003	as	abstract[98]	new[98]	_	_
13-8	2004-2005	a	abstract[98]	new[98]	_	_
13-9	2006-2017	consequence	abstract[98]	new[98]	_	_
13-10	2018-2020	of	abstract[98]	new[98]	_	_
13-11	2021-2031	infections	abstract[98]|abstract[99]	new[98]|giv[99]	coref	14-5[105_99]
13-12	2032-2033	,	abstract[98]|abstract[99]	new[98]|giv[99]	_	_
13-13	2034-2043	including	abstract[98]|abstract[99]	new[98]|giv[99]	_	_
13-14	2044-2050	higher	abstract[98]|abstract[99]|event[100]	new[98]|giv[99]|giv[100]	_	_
13-15	2051-2060	mortality	abstract[98]|abstract[99]|event[100]	new[98]|giv[99]|giv[100]	_	_
13-16	2061-2062	,	_	_	_	_
13-17	2063-2071	compared	_	_	_	_
13-18	2072-2074	to	_	_	_	_
13-19	2075-2081	adults	person[101]	giv[101]	coref	15-3[115_101]
13-20	2082-2084	of	person[101]	giv[101]	_	_
13-21	2085-2090	other	person[101]|person[103]	giv[101]|new[103]	coref	26-28[217_103]
13-22	2091-2094	age	person[101]|abstract|person[103]	giv[101]|new|new[103]	_	_
13-23	2095-2101	groups	person[101]|person[103]	giv[101]|new[103]	_	_
13-24	2102-2103	.	_	_	_	_

#Text=Atypical clinical presentations of infections , undertreatment or overtreatment , high risk of multidrug-resistant organism acquisition , rapid disease progression and prolonged recovery all contribute to poorer outcomes in the elderly .
14-1	2104-2112	Atypical	abstract[104]	new[104]	_	_
14-2	2113-2121	clinical	abstract[104]	new[104]	_	_
14-3	2122-2135	presentations	abstract[104]	new[104]	_	_
14-4	2136-2138	of	abstract[104]	new[104]	_	_
14-5	2139-2149	infections	abstract[104]|abstract[105]	new[104]|giv[105]	coref	16-30[130_105]
14-6	2150-2151	,	abstract[104]|abstract[105]	new[104]|giv[105]	_	_
14-7	2152-2166	undertreatment	abstract[104]|abstract[105]|abstract	new[104]|giv[105]|new	_	_
14-8	2167-2169	or	abstract[104]|abstract[105]	new[104]|giv[105]	_	_
14-9	2170-2183	overtreatment	abstract[104]|abstract[105]|event	new[104]|giv[105]|new	_	_
14-10	2184-2185	,	abstract[104]|abstract[105]	new[104]|giv[105]	_	_
14-11	2186-2190	high	abstract[104]|abstract[105]|abstract[108]	new[104]|giv[105]|new[108]	_	_
14-12	2191-2195	risk	abstract[104]|abstract[105]|abstract[108]	new[104]|giv[105]|new[108]	_	_
14-13	2196-2198	of	abstract[104]|abstract[105]|abstract[108]	new[104]|giv[105]|new[108]	_	_
14-14	2199-2218	multidrug-resistant	abstract[104]|abstract[105]|abstract[108]|event[110]	new[104]|giv[105]|new[108]|new[110]	_	_
14-15	2219-2227	organism	abstract[104]|abstract[105]|abstract[108]|abstract|event[110]	new[104]|giv[105]|new[108]|new|new[110]	_	_
14-16	2228-2239	acquisition	abstract[104]|abstract[105]|abstract[108]|event[110]	new[104]|giv[105]|new[108]|new[110]	_	_
14-17	2240-2241	,	abstract[104]|abstract[105]|abstract[108]	new[104]|giv[105]|new[108]	_	_
14-18	2242-2247	rapid	abstract[104]|abstract[105]|abstract[108]|abstract[112]	new[104]|giv[105]|new[108]|new[112]	_	_
14-19	2248-2255	disease	abstract[104]|abstract[105]|abstract[108]|abstract|abstract[112]	new[104]|giv[105]|new[108]|new|new[112]	_	_
14-20	2256-2267	progression	abstract[104]|abstract[105]|abstract[108]|abstract[112]	new[104]|giv[105]|new[108]|new[112]	_	_
14-21	2268-2271	and	abstract[104]|abstract[105]|abstract[108]	new[104]|giv[105]|new[108]	_	_
14-22	2272-2281	prolonged	abstract[104]|abstract[105]|abstract[108]|event[113]	new[104]|giv[105]|new[108]|new[113]	coref	25-31[206_113]
14-23	2282-2290	recovery	abstract[104]|abstract[105]|abstract[108]|event[113]	new[104]|giv[105]|new[108]|new[113]	_	_
14-24	2291-2294	all	_	_	_	_
14-25	2295-2305	contribute	_	_	_	_
14-26	2306-2308	to	_	_	_	_
14-27	2309-2315	poorer	abstract[114]	giv[114]	_	_
14-28	2316-2324	outcomes	abstract[114]	giv[114]	_	_
14-29	2325-2327	in	_	_	_	_
14-30	2328-2331	the	_	_	_	_
14-31	2332-2339	elderly	_	_	_	_
14-32	2340-2341	.	_	_	_	_

#Text=Moreover , older adults who were living alone have lower health literacy and hence lower self-management abilities , contributing to poorer health .
15-1	2342-2350	Moreover	_	_	_	_
15-2	2351-2352	,	_	_	_	_
15-3	2353-2358	older	person[115]	giv[115]	ana	16-21[0_115]
15-4	2359-2365	adults	person[115]	giv[115]	_	_
15-5	2366-2369	who	_	_	_	_
15-6	2370-2374	were	_	_	_	_
15-7	2375-2381	living	_	_	_	_
15-8	2382-2387	alone	_	_	_	_
15-9	2388-2392	have	_	_	_	_
15-10	2393-2398	lower	abstract[117]	new[117]	_	_
15-11	2399-2405	health	abstract|abstract[117]	giv|new[117]	coref	15-21[120_0]
15-12	2406-2414	literacy	abstract[117]	new[117]	_	_
15-13	2415-2418	and	_	_	_	_
15-14	2419-2424	hence	abstract[119]	new[119]	_	_
15-15	2425-2430	lower	abstract[119]	new[119]	_	_
15-16	2431-2446	self-management	abstract|abstract[119]	new|new[119]	_	_
15-17	2447-2456	abilities	abstract[119]	new[119]	_	_
15-18	2457-2458	,	_	_	_	_
15-19	2459-2471	contributing	_	_	_	_
15-20	2472-2474	to	_	_	_	_
15-21	2475-2481	poorer	abstract[120]	giv[120]	_	_
15-22	2482-2488	health	abstract[120]	giv[120]	_	_
15-23	2489-2490	.	_	_	_	_

#Text=A lack of knowledge on antibiotic use in the general public has been reported , with more than half of them who thought that antibiotics are useful in treating viral infections , and about one half of them would stop taking antibiotics when they felt better .
16-1	2491-2492	A	abstract[121]	new[121]	_	_
16-2	2493-2497	lack	abstract[121]	new[121]	_	_
16-3	2498-2500	of	abstract[121]	new[121]	_	_
16-4	2501-2510	knowledge	abstract[121]|abstract[122]	new[121]|new[122]	coref	18-4[142_122]
16-5	2511-2513	on	abstract[121]|abstract[122]	new[121]|new[122]	_	_
16-6	2514-2524	antibiotic	abstract[121]|abstract[122]|substance|abstract[124]	new[121]|new[122]|giv|giv[124]	coref|coref|coref|coref	17-6|18-7[144_124]|17-6|18-7[144_124]
16-7	2525-2528	use	abstract[121]|abstract[122]|abstract[124]	new[121]|new[122]|giv[124]	_	_
16-8	2529-2531	in	abstract[121]|abstract[122]|abstract[124]	new[121]|new[122]|giv[124]	_	_
16-9	2532-2535	the	abstract[121]|abstract[122]|abstract[124]|person[125]	new[121]|new[122]|giv[124]|new[125]	_	_
16-10	2536-2543	general	abstract[121]|abstract[122]|abstract[124]|person[125]	new[121]|new[122]|giv[124]|new[125]	_	_
16-11	2544-2550	public	abstract[121]|abstract[122]|abstract[124]|person[125]	new[121]|new[122]|giv[124]|new[125]	_	_
16-12	2551-2554	has	_	_	_	_
16-13	2555-2559	been	_	_	_	_
16-14	2560-2568	reported	_	_	_	_
16-15	2569-2570	,	_	_	_	_
16-16	2571-2575	with	_	_	_	_
16-17	2576-2580	more	_	_	_	_
16-18	2581-2585	than	_	_	_	_
16-19	2586-2590	half	quantity[126]	new[126]	_	_
16-20	2591-2593	of	quantity[126]	new[126]	_	_
16-21	2594-2598	them	quantity[126]|person	new[126]|giv	ana	16-38
16-22	2599-2602	who	_	_	_	_
16-23	2603-2610	thought	_	_	_	_
16-24	2611-2615	that	_	_	_	_
16-25	2616-2627	antibiotics	substance	new	coref	16-42
16-26	2628-2631	are	_	_	_	_
16-27	2632-2638	useful	_	_	_	_
16-28	2639-2641	in	_	_	_	_
16-29	2642-2650	treating	_	_	_	_
16-30	2651-2656	viral	object|abstract[130]	new|giv[130]	coref|coref	23-14[189_130]|23-14[189_130]
16-31	2657-2667	infections	abstract[130]	giv[130]	_	_
16-32	2668-2669	,	_	_	_	_
16-33	2670-2673	and	_	_	_	_
16-34	2674-2679	about	quantity[131]	new[131]	_	_
16-35	2680-2683	one	quantity[131]	new[131]	_	_
16-36	2684-2688	half	quantity[131]	new[131]	_	_
16-37	2689-2691	of	quantity[131]	new[131]	_	_
16-38	2692-2696	them	quantity[131]|person	new[131]|giv	ana	16-44
16-39	2697-2702	would	_	_	_	_
16-40	2703-2707	stop	_	_	_	_
16-41	2708-2714	taking	_	_	_	_
16-42	2715-2726	antibiotics	substance	giv	coref	17-13
16-43	2727-2731	when	_	_	_	_
16-44	2732-2736	they	person	giv	ana	17-1
16-45	2737-2741	felt	_	_	_	_
16-46	2742-2748	better	_	_	_	_
16-47	2749-2750	.	_	_	_	_

#Text=Those who were aware of antibiotic resistance were unaware that misuse of antibiotics could lead to this global crisis .
17-1	2751-2756	Those	person	giv	ana	18-1
17-2	2757-2760	who	_	_	_	_
17-3	2761-2765	were	_	_	_	_
17-4	2766-2771	aware	_	_	_	_
17-5	2772-2774	of	_	_	_	_
17-6	2775-2785	antibiotic	substance|abstract[137]	giv|giv[137]	coref|coref|coref|coref	18-7|21-19[176_137]|18-7|21-19[176_137]
17-7	2786-2796	resistance	abstract[137]	giv[137]	_	_
17-8	2797-2801	were	_	_	_	_
17-9	2802-2809	unaware	_	_	_	_
17-10	2810-2814	that	_	_	_	_
17-11	2815-2821	misuse	abstract[138]	new[138]	_	_
17-12	2822-2824	of	abstract[138]	new[138]	_	_
17-13	2825-2836	antibiotics	abstract[138]|substance	new[138]|giv	coref	18-22[149_0]
17-14	2837-2842	could	_	_	_	_
17-15	2843-2847	lead	_	_	_	_
17-16	2848-2850	to	_	_	_	_
17-17	2851-2855	this	abstract[140]	giv[140]	_	_
17-18	2856-2862	global	abstract[140]	giv[140]	_	_
17-19	2863-2869	crisis	abstract[140]	giv[140]	_	_
17-20	2870-2871	.	_	_	_	_

#Text=Those who had poor knowledge of antibiotic use were associated with a higher probability of antibiotic self-medication and practices of using leftover antibiotics , sharing antibiotics , keeping antibiotics for future use and stopping antibiotics when symptoms disappear .
18-1	2872-2877	Those	person	giv	coref	19-16[158_0]
18-2	2878-2881	who	_	_	_	_
18-3	2882-2885	had	_	_	_	_
18-4	2886-2890	poor	abstract[142]	giv[142]	_	_
18-5	2891-2900	knowledge	abstract[142]	giv[142]	_	_
18-6	2901-2903	of	abstract[142]	giv[142]	_	_
18-7	2904-2914	antibiotic	abstract[142]|substance|abstract[144]	giv[142]|giv|giv[144]	coref|coref|coref|coref	18-16|18-31[152_144]|18-16|18-31[152_144]
18-8	2915-2918	use	abstract[142]|abstract[144]	giv[142]|giv[144]	_	_
18-9	2919-2923	were	_	_	_	_
18-10	2924-2934	associated	_	_	_	_
18-11	2935-2939	with	_	_	_	_
18-12	2940-2941	a	abstract[145]	new[145]	_	_
18-13	2942-2948	higher	abstract[145]	new[145]	_	_
18-14	2949-2960	probability	abstract[145]	new[145]	_	_
18-15	2961-2963	of	abstract[145]	new[145]	_	_
18-16	2964-2974	antibiotic	abstract[145]|substance|abstract[147]	new[145]|giv|new[147]	coref|coref|coref|coref	19-8[0_147]|20-17|19-8[0_147]|20-17
18-17	2975-2990	self-medication	abstract[145]|abstract[147]	new[145]|new[147]	_	_
18-18	2991-2994	and	abstract[145]	new[145]	_	_
18-19	2995-3004	practices	abstract[145]|abstract	new[145]|new	coref	19-1[155_0]
18-20	3005-3007	of	_	_	_	_
18-21	3008-3013	using	_	_	_	_
18-22	3014-3022	leftover	substance[149]	giv[149]	coref	18-26[0_149]
18-23	3023-3034	antibiotics	substance[149]	giv[149]	_	_
18-24	3035-3036	,	_	_	_	_
18-25	3037-3044	sharing	_	_	_	_
18-26	3045-3056	antibiotics	substance	giv	coref	18-29[151_0]
18-27	3057-3058	,	_	_	_	_
18-28	3059-3066	keeping	_	_	_	_
18-29	3067-3078	antibiotics	substance[151]	giv[151]	coref	18-35[0_151]
18-30	3079-3082	for	substance[151]	giv[151]	_	_
18-31	3083-3089	future	substance[151]|abstract[152]	giv[151]|giv[152]	coref	20-17[164_152]
18-32	3090-3093	use	substance[151]|abstract[152]	giv[151]|giv[152]	_	_
18-33	3094-3097	and	_	_	_	_
18-34	3098-3106	stopping	_	_	_	_
18-35	3107-3118	antibiotics	substance	giv	coref	19-5[156_0]
18-36	3119-3123	when	_	_	_	_
18-37	3124-3132	symptoms	abstract	new	_	_
18-38	3133-3142	disappear	_	_	_	_
18-39	3143-3144	.	_	_	_	_

#Text=Inappropriate practices related to antibiotics , including self-medication , were reported to be common among older adults .
19-1	3145-3158	Inappropriate	abstract[155]	giv[155]	coref	28-14[0_155]
19-2	3159-3168	practices	abstract[155]	giv[155]	_	_
19-3	3169-3176	related	_	_	_	_
19-4	3177-3179	to	_	_	_	_
19-5	3180-3191	antibiotics	substance[156]	giv[156]	coref	20-31[0_156]
19-6	3192-3193	,	substance[156]	giv[156]	_	_
19-7	3194-3203	including	substance[156]	giv[156]	_	_
19-8	3204-3219	self-medication	substance[156]|abstract	giv[156]|giv	_	_
19-9	3220-3221	,	_	_	_	_
19-10	3222-3226	were	_	_	_	_
19-11	3227-3235	reported	_	_	_	_
19-12	3236-3238	to	_	_	_	_
19-13	3239-3241	be	_	_	_	_
19-14	3242-3248	common	_	_	_	_
19-15	3249-3254	among	_	_	_	_
19-16	3255-3260	older	person[158]	giv[158]	coref	20-9[161_158]
19-17	3261-3267	adults	person[158]	giv[158]	_	_
19-18	3268-3269	.	_	_	_	_

#Text=In one study , a considerable proportion of older adults ( 77.8 % ) who had antibiotic use within the past six months were found to have experience of receiving antibiotics without prescriptions .
20-1	3270-3272	In	_	_	_	_
20-2	3273-3276	one	abstract[159]	new[159]	coref	27-13[223_159]
20-3	3277-3282	study	abstract[159]	new[159]	_	_
20-4	3283-3284	,	_	_	_	_
20-5	3285-3286	a	quantity[160]	new[160]	_	_
20-6	3287-3299	considerable	quantity[160]	new[160]	_	_
20-7	3300-3310	proportion	quantity[160]	new[160]	_	_
20-8	3311-3313	of	quantity[160]	new[160]	_	_
20-9	3314-3319	older	quantity[160]|person[161]	new[160]|giv[161]	coref	21-21[177_161]
20-10	3320-3326	adults	quantity[160]|person[161]	new[160]|giv[161]	_	_
20-11	3327-3328	(	_	_	_	_
20-12	3329-3333	77.8	quantity[162]	new[162]	_	_
20-13	3334-3335	%	quantity[162]	new[162]	_	_
20-14	3336-3337	)	_	_	_	_
20-15	3338-3341	who	_	_	_	_
20-16	3342-3345	had	_	_	_	_
20-17	3346-3356	antibiotic	substance|abstract[164]	giv|giv[164]	coref|coref|coref|coref	21-16|21-16[174_164]|21-16|21-16[174_164]
20-18	3357-3360	use	abstract[164]	giv[164]	_	_
20-19	3361-3367	within	_	_	_	_
20-20	3368-3371	the	time[165]	new[165]	_	_
20-21	3372-3376	past	time[165]	new[165]	_	_
20-22	3377-3380	six	time[165]	new[165]	_	_
20-23	3381-3387	months	time[165]	new[165]	_	_
20-24	3388-3392	were	_	_	_	_
20-25	3393-3398	found	_	_	_	_
20-26	3399-3401	to	_	_	_	_
20-27	3402-3406	have	_	_	_	_
20-28	3407-3417	experience	abstract	new	_	_
20-29	3418-3420	of	_	_	_	_
20-30	3421-3430	receiving	_	_	_	_
20-31	3431-3442	antibiotics	substance	giv	coref	22-18
20-32	3443-3450	without	_	_	_	_
20-33	3451-3464	prescriptions	abstract	giv	_	_
20-34	3465-3466	.	_	_	_	_

#Text=However , only a few studies reported the lack of knowledge and poor attitude on antibiotic use and resistance among older adults .
21-1	3467-3474	However	_	_	_	_
21-2	3475-3476	,	_	_	_	_
21-3	3477-3481	only	event[169]	new[169]	_	_
21-4	3482-3483	a	event[169]	new[169]	_	_
21-5	3484-3487	few	event[169]	new[169]	_	_
21-6	3488-3495	studies	event[169]	new[169]	_	_
21-7	3496-3504	reported	_	_	_	_
21-8	3505-3508	the	abstract[170]	new[170]	_	_
21-9	3509-3513	lack	abstract[170]	new[170]	_	_
21-10	3514-3516	of	abstract[170]	new[170]	_	_
21-11	3517-3526	knowledge	abstract[170]|abstract	new[170]|new	coref	26-2[208_0]
21-12	3527-3530	and	abstract[170]	new[170]	_	_
21-13	3531-3535	poor	abstract[170]|abstract[172]	new[170]|new[172]	_	_
21-14	3536-3544	attitude	abstract[170]|abstract[172]	new[170]|new[172]	_	_
21-15	3545-3547	on	abstract[170]|abstract[172]	new[170]|new[172]	_	_
21-16	3548-3558	antibiotic	abstract[170]|abstract[172]|substance|abstract[174]|abstract[175]	new[170]|new[172]|giv|giv[174]|new[175]	coref|coref|coref|coref|coref|coref|coref|coref|coref	22-9|26-15[212_174]|26-15[213_175]|22-9|26-15[212_174]|26-15[213_175]|22-9|26-15[212_174]|26-15[213_175]
21-17	3559-3562	use	abstract[170]|abstract[172]|abstract[174]|abstract[175]	new[170]|new[172]|giv[174]|new[175]	_	_
21-18	3563-3566	and	abstract[170]|abstract[172]|abstract[175]	new[170]|new[172]|new[175]	_	_
21-19	3567-3577	resistance	abstract[170]|abstract[172]|abstract[175]|abstract[176]	new[170]|new[172]|new[175]|giv[176]	coref	26-18[0_176]
21-20	3578-3583	among	abstract[170]|abstract[172]|abstract[175]|abstract[176]	new[170]|new[172]|new[175]|giv[176]	_	_
21-21	3584-3589	older	abstract[170]|abstract[172]|abstract[175]|abstract[176]|person[177]	new[170]|new[172]|new[175]|giv[176]|giv[177]	coref	25-10[201_177]
21-22	3590-3596	adults	abstract[170]|abstract[172]|abstract[175]|abstract[176]|person[177]	new[170]|new[172]|new[175]|giv[176]|giv[177]	_	_
21-23	3597-3598	.	_	_	_	_

#Text=Patients who were unaware of the consequences of antibiotic overuse to the community were found to expect antibiotics from their prescriber .
22-1	3599-3607	Patients	person	new	ana	22-20
22-2	3608-3611	who	_	_	_	_
22-3	3612-3616	were	_	_	_	_
22-4	3617-3624	unaware	_	_	_	_
22-5	3625-3627	of	_	_	_	_
22-6	3628-3631	the	abstract[179]	new[179]	_	_
22-7	3632-3644	consequences	abstract[179]	new[179]	_	_
22-8	3645-3647	of	abstract[179]	new[179]	_	_
22-9	3648-3658	antibiotic	abstract[179]|substance|abstract[181]	new[179]|giv|giv[181]	coref|coref	24-14|24-14
22-10	3659-3666	overuse	abstract[179]|abstract[181]	new[179]|giv[181]	_	_
22-11	3667-3669	to	abstract[179]|abstract[181]	new[179]|giv[181]	_	_
22-12	3670-3673	the	abstract[179]|abstract[181]|organization[182]	new[179]|giv[181]|new[182]	_	_
22-13	3674-3683	community	abstract[179]|abstract[181]|organization[182]	new[179]|giv[181]|new[182]	_	_
22-14	3684-3688	were	_	_	_	_
22-15	3689-3694	found	_	_	_	_
22-16	3695-3697	to	_	_	_	_
22-17	3698-3704	expect	_	_	_	_
22-18	3705-3716	antibiotics	substance	giv	coref	23-10
22-19	3717-3721	from	_	_	_	_
22-20	3722-3727	their	person|object[185]	giv|new[185]	ana|ana	23-5|23-5
22-21	3728-3738	prescriber	object[185]	new[185]	_	_
22-22	3739-3740	.	_	_	_	_

#Text=Studies have found that those who incorrectly believed that antibiotics will work for viral infections were more likely to expect antibiotics from prescribers .
23-1	3741-3748	Studies	abstract	new	coref	26-5[209_0]
23-2	3749-3753	have	_	_	_	_
23-3	3754-3759	found	_	_	_	_
23-4	3760-3764	that	_	_	_	_
23-5	3765-3770	those	person	giv	coref	24-1[192_0]
23-6	3771-3774	who	_	_	_	_
23-7	3775-3786	incorrectly	_	_	_	_
23-8	3787-3795	believed	_	_	_	_
23-9	3796-3800	that	_	_	_	_
23-10	3801-3812	antibiotics	substance	giv	coref	23-21
23-11	3813-3817	will	_	_	_	_
23-12	3818-3822	work	_	_	_	_
23-13	3823-3826	for	_	_	_	_
23-14	3827-3832	viral	abstract[189]	giv[189]	_	_
23-15	3833-3843	infections	abstract[189]	giv[189]	_	_
23-16	3844-3848	were	_	_	_	_
23-17	3849-3853	more	_	_	_	_
23-18	3854-3860	likely	_	_	_	_
23-19	3861-3863	to	_	_	_	_
23-20	3864-3870	expect	_	_	_	_
23-21	3871-3882	antibiotics	substance	giv	coref	24-5
23-22	3883-3887	from	_	_	_	_
23-23	3888-3899	prescribers	person	new	_	_
23-24	3900-3901	.	_	_	_	_

#Text=Patients â€™ expectations of antibiotics are found to be an important predictor of antibiotic prescribing .
24-1	3902-3910	Patients	person[192]|abstract[193]	giv[192]|new[193]	coref|coref	25-1[198_193]|25-1[198_193]
24-2	3911-3912	â€™	person[192]|abstract[193]	giv[192]|new[193]	_	_
24-3	3913-3925	expectations	abstract[193]	new[193]	_	_
24-4	3926-3928	of	abstract[193]	new[193]	_	_
24-5	3929-3940	antibiotics	abstract[193]|substance	new[193]|giv	coref	25-3[199_0]
24-6	3941-3944	are	_	_	_	_
24-7	3945-3950	found	_	_	_	_
24-8	3951-3953	to	_	_	_	_
24-9	3954-3956	be	_	_	_	_
24-10	3957-3959	an	abstract[195]	new[195]	_	_
24-11	3960-3969	important	abstract[195]	new[195]	_	_
24-12	3970-3979	predictor	abstract[195]	new[195]	_	_
24-13	3980-3982	of	abstract[195]	new[195]	_	_
24-14	3983-3993	antibiotic	abstract[195]|substance|abstract[197]	new[195]|giv|new[197]	coref|coref	26-15|26-15
24-15	3994-4005	prescribing	abstract[195]|abstract[197]	new[195]|new[197]	_	_
24-16	4006-4007	.	_	_	_	_

#Text=Expectations for antibiotics for common cold were found among older adults when they felt sick enough to visit a physician , although most of them disagreed that antibiotics could speed the recovery .
25-1	4008-4020	Expectations	abstract[198]	giv[198]	coref	27-32[233_198]
25-2	4021-4024	for	abstract[198]	giv[198]	_	_
25-3	4025-4036	antibiotics	abstract[198]|substance[199]	giv[198]|giv[199]	coref	25-28[0_199]
25-4	4037-4040	for	abstract[198]|substance[199]	giv[198]|giv[199]	_	_
25-5	4041-4047	common	abstract[198]|substance[199]|abstract[200]	giv[198]|giv[199]|new[200]	_	_
25-6	4048-4052	cold	abstract[198]|substance[199]|abstract[200]	giv[198]|giv[199]|new[200]	_	_
25-7	4053-4057	were	_	_	_	_
25-8	4058-4063	found	_	_	_	_
25-9	4064-4069	among	_	_	_	_
25-10	4070-4075	older	person[201]	giv[201]	ana	25-13[0_201]
25-11	4076-4082	adults	person[201]	giv[201]	_	_
25-12	4083-4087	when	_	_	_	_
25-13	4088-4092	they	person	giv	ana	25-25
25-14	4093-4097	felt	_	_	_	_
25-15	4098-4102	sick	_	_	_	_
25-16	4103-4109	enough	_	_	_	_
25-17	4110-4112	to	_	_	_	_
25-18	4113-4118	visit	_	_	_	_
25-19	4119-4120	a	person[203]	new[203]	_	_
25-20	4121-4130	physician	person[203]	new[203]	_	_
25-21	4131-4132	,	_	_	_	_
25-22	4133-4141	although	_	_	_	_
25-23	4142-4146	most	_	_	_	_
25-24	4147-4149	of	_	_	_	_
25-25	4150-4154	them	person	giv	coref	26-33[218_0]
25-26	4155-4164	disagreed	_	_	_	_
25-27	4165-4169	that	_	_	_	_
25-28	4170-4181	antibiotics	substance	giv	coref	27-38
25-29	4182-4187	could	_	_	_	_
25-30	4188-4193	speed	_	_	_	_
25-31	4194-4197	the	event[206]	giv[206]	_	_
25-32	4198-4206	recovery	event[206]	giv[206]	_	_
25-33	4207-4208	.	_	_	_	_

#Text=To our knowledge , many studies have been done to assess the knowledge of antibiotic use and resistance ; however , there has been limited research targeting vulnerable population groups , including older adults .
26-1	4209-4211	To	_	_	_	_
26-2	4212-4215	our	person|abstract[208]	acc|giv[208]	ana|ana	27-11|27-11
26-3	4216-4225	knowledge	abstract[208]	giv[208]	_	_
26-4	4226-4227	,	_	_	_	_
26-5	4228-4232	many	abstract[209]	giv[209]	_	_
26-6	4233-4240	studies	abstract[209]	giv[209]	_	_
26-7	4241-4245	have	_	_	_	_
26-8	4246-4250	been	_	_	_	_
26-9	4251-4255	done	_	_	_	_
26-10	4256-4258	to	_	_	_	_
26-11	4259-4265	assess	_	_	_	_
26-12	4266-4269	the	abstract[210]	new[210]	coref	27-24[227_210]
26-13	4270-4279	knowledge	abstract[210]	new[210]	_	_
26-14	4280-4282	of	abstract[210]	new[210]	_	_
26-15	4283-4293	antibiotic	abstract[210]|substance|abstract[212]|abstract[213]	new[210]|giv|giv[212]|giv[213]	ana|coref|coref|ana|coref|coref|ana|coref|coref	27-24[0_213]|27-27|27-27[229_212]|27-24[0_213]|27-27|27-27[229_212]|27-24[0_213]|27-27|27-27[229_212]
26-16	4294-4297	use	abstract[210]|abstract[212]|abstract[213]	new[210]|giv[212]|giv[213]	_	_
26-17	4298-4301	and	abstract[210]|abstract[213]	new[210]|giv[213]	_	_
26-18	4302-4312	resistance	abstract[210]|abstract[213]|abstract	new[210]|giv[213]|giv	coref	27-30
26-19	4313-4314	;	_	_	_	_
26-20	4315-4322	however	_	_	_	_
26-21	4323-4324	,	_	_	_	_
26-22	4325-4330	there	_	_	_	_
26-23	4331-4334	has	_	_	_	_
26-24	4335-4339	been	_	_	_	_
26-25	4340-4347	limited	abstract[215]	new[215]	_	_
26-26	4348-4356	research	abstract[215]	new[215]	_	_
26-27	4357-4366	targeting	_	_	_	_
26-28	4367-4377	vulnerable	person[217]	giv[217]	_	_
26-29	4378-4388	population	abstract|person[217]	new|giv[217]	_	_
26-30	4389-4395	groups	person[217]	giv[217]	_	_
26-31	4396-4397	,	person[217]	giv[217]	_	_
26-32	4398-4407	including	person[217]	giv[217]	_	_
26-33	4408-4413	older	person[217]|person[218]	giv[217]|giv[218]	coref	28-20[242_218]
26-34	4414-4420	adults	person[217]|person[218]	giv[217]|giv[218]	_	_
26-35	4421-4422	.	_	_	_	_

#Text=Due to the paucity of information in this area , we conducted a study among the older adult population in Malaysia to assess their knowledge on antibiotic use and resistance and their expectations towards the need for antibiotics .
27-1	4423-4426	Due	_	_	_	_
27-2	4427-4429	to	_	_	_	_
27-3	4430-4433	the	abstract[219]	new[219]	_	_
27-4	4434-4441	paucity	abstract[219]	new[219]	_	_
27-5	4442-4444	of	abstract[219]	new[219]	_	_
27-6	4445-4456	information	abstract[219]|abstract	new[219]|new	_	_
27-7	4457-4459	in	abstract[219]	new[219]	_	_
27-8	4460-4464	this	abstract[219]|abstract[221]	new[219]|new[221]	_	_
27-9	4465-4469	area	abstract[219]|abstract[221]	new[219]|new[221]	_	_
27-10	4470-4471	,	_	_	_	_
27-11	4472-4474	we	person	giv	_	_
27-12	4475-4484	conducted	_	_	_	_
27-13	4485-4486	a	abstract[223]	giv[223]	coref	28-1[236_223]
27-14	4487-4492	study	abstract[223]	giv[223]	_	_
27-15	4493-4498	among	abstract[223]	giv[223]	_	_
27-16	4499-4502	the	abstract[223]|person[224]	giv[223]|giv[224]	_	_
27-17	4503-4508	older	abstract[223]|person[224]	giv[223]|giv[224]	_	_
27-18	4509-4514	adult	abstract[223]|person[224]	giv[223]|giv[224]	_	_
27-19	4515-4525	population	abstract[223]|person[224]	giv[223]|giv[224]	_	_
27-20	4526-4528	in	abstract[223]|person[224]	giv[223]|giv[224]	_	_
27-21	4529-4537	Malaysia	abstract[223]|person[224]|place	giv[223]|giv[224]|giv	_	_
27-22	4538-4540	to	_	_	_	_
27-23	4541-4547	assess	_	_	_	_
27-24	4548-4553	their	abstract|abstract[227]	giv|giv[227]	ana|coref|ana|coref	27-32|28-10[0_227]|27-32|28-10[0_227]
27-25	4554-4563	knowledge	abstract[227]	giv[227]	_	_
27-26	4564-4566	on	abstract[227]	giv[227]	_	_
27-27	4567-4577	antibiotic	abstract[227]|substance|abstract[229]|abstract[230]	giv[227]|giv|giv[229]|giv[230]	coref|coref|coref	28-17|28-17|28-17
27-28	4578-4581	use	abstract[227]|abstract[229]|abstract[230]	giv[227]|giv[229]|giv[230]	_	_
27-29	4582-4585	and	abstract[227]|abstract[230]	giv[227]|giv[230]	_	_
27-30	4586-4596	resistance	abstract[227]|abstract[230]|abstract	giv[227]|giv[230]|giv	_	_
27-31	4597-4600	and	abstract[227]|abstract[230]	giv[227]|giv[230]	_	_
27-32	4601-4606	their	abstract[227]|abstract[230]|abstract|abstract[233]	giv[227]|giv[230]|giv|giv[233]	coref|coref	28-12[0_233]|28-12[0_233]
27-33	4607-4619	expectations	abstract[227]|abstract[230]|abstract[233]	giv[227]|giv[230]|giv[233]	_	_
27-34	4620-4627	towards	abstract[227]|abstract[230]|abstract[233]	giv[227]|giv[230]|giv[233]	_	_
27-35	4628-4631	the	abstract[227]|abstract[230]|abstract[233]|abstract[234]	giv[227]|giv[230]|giv[233]|new[234]	_	_
27-36	4632-4636	need	abstract[227]|abstract[230]|abstract[233]|abstract[234]	giv[227]|giv[230]|giv[233]|new[234]	_	_
27-37	4637-4640	for	abstract[227]|abstract[230]|abstract[233]|abstract[234]	giv[227]|giv[230]|giv[233]|new[234]	_	_
27-38	4641-4652	antibiotics	abstract[227]|abstract[230]|abstract[233]|abstract[234]|substance	giv[227]|giv[230]|giv[233]|new[234]|giv	_	_
27-39	4653-4654	.	_	_	_	_

#Text=This study also aimed to assess the relationship between knowledge , expectations and practices related to antibiotic use among older adults .
28-1	4655-4659	This	abstract[236]	giv[236]	_	_
28-2	4660-4665	study	abstract[236]	giv[236]	_	_
28-3	4666-4670	also	_	_	_	_
28-4	4671-4676	aimed	_	_	_	_
28-5	4677-4679	to	_	_	_	_
28-6	4680-4686	assess	_	_	_	_
28-7	4687-4690	the	abstract[237]	new[237]	_	_
28-8	4691-4703	relationship	abstract[237]	new[237]	_	_
28-9	4704-4711	between	abstract[237]	new[237]	_	_
28-10	4712-4721	knowledge	abstract[237]|abstract	new[237]|giv	_	_
28-11	4722-4723	,	abstract[237]	new[237]	_	_
28-12	4724-4736	expectations	abstract[237]|abstract	new[237]|giv	_	_
28-13	4737-4740	and	abstract[237]	new[237]	_	_
28-14	4741-4750	practices	abstract[237]|abstract	new[237]|giv	_	_
28-15	4751-4758	related	_	_	_	_
28-16	4759-4761	to	_	_	_	_
28-17	4762-4772	antibiotic	substance	giv	_	_
28-18	4773-4776	use	_	_	_	_
28-19	4777-4782	among	_	_	_	_
28-20	4783-4788	older	person[242]	giv[242]	_	_
28-21	4789-4795	adults	person[242]	giv[242]	_	_
28-22	4796-4797	.	_	_	_	_
